top of page
for professionals_2638426297.jpg

For Professionals

Advancing Clinical Neuroscience Through Collaboration 

The Clinical Neuroscience Consortium (CNC) brings together clinicians, researchers, educators, and industry partners to advance neuroscience research, education, and patient care through collaboration. We provide a platform for cross‑disciplinary, cross‑institutional partnerships that translate scientific discovery into meaningful clinical impact.

Clinicians Neurologists, neurosurgeons, neuro‑oncologists, neuroradiologists,

Who We Work With 

CNC welcomes collaboration with professionals across the neuroscience ecosystem, including: 

Clinicians 

Neurologists, neurosurgeons, neuro‑oncologists, neuroradiologists, neuro‑anaesthesiologists, pain specialists, rehabilitation professionals, and allied health colleagues. 

neuro‑anaesthesiologists, pain specialists, rehabilitation professionals, and allied health colleagues
Researchers and Academics 

Basic scientists, clinical researchers, translational scientists, epidemiologists, data scientists, and educators. 

Researchers and Academics Basic scientists, clinical researchers, translational scientists

Industry and Innovation Partners

Medical device, biotech and pharmaceutical companies, digital health and AI developers, and technology innovators. 

Epidemiologists, data scientists, and educators

Area of Collaboration 

Brain Tumour

Our translational research bridges laboratory discoveries with clinical practice through close collaboration with neuroscientists, oncologists, and global experts in brain tumour research. • Precision oncology using molecular tumour sequencing to identify tumour-specific genetic and molecular alterations • Clinical trials to explore novel therapies, including biomarker‑driven and targeted therapies, for recurrent and aggressive brain tumours

Cognitive Disorders and Dementia

We work across specialties, including neurologists, geriatricians and neuroradiologists, to improve diagnosis and monitoring of cognitive disorders, with a focus on Alzheimer’s disease (AD). • Clinical use of plasma biomarkers for diagnosis of AD • Advanced neuroimaging in diagnosis and monitoring of disease progression in AD

Movement Disorders

We seek local and international collaboration to advance research and care in movement disorders, such as Parkinson's disease, dystonia and Tourette syndrome. • Clinical and translational research across movement disorders • Deep brain stimulation (DBS) and magnetic resonance-guided focused ultrasound (MRgFUS) in treating Parkinson’s disease and related disorders • Knowledge exchange and joint educational initiatives

Neuro‑immunological Disorders

Our neurologists, neuroradiologists and neuroscientists collaborate to advance understanding and management of neuro‑immunological diseases. • Development of advanced neuroimaging biomarkers for monitoring disease progression and treatment response • Translational research on emerging immunotherapies

Neuromuscular Disorders

We collaborate with local, regional and overseas partners to advance precision medicine for neuromuscular disorders through multidisciplinary, translational work. Our ongoing projects include: • Spinal Muscular Atrophy (SMA) Receiving Genetic Disease-modifying Treatments • Hong Kong Neuromuscular Diseases (NMDs) Patient Registry • AI-Enabled Deep Phenotyping and Data Standardization for Improved Management of Genetic Neuromuscular Disorders (NMDs) • NMD Patient-Derived iPSC Models and Drug Screening for Dystrophinopathy

Neurospine

Our neurospine collaborations integrate basic science, clinical research, and rehabilitation. • Basic and translational studies on biological adjuncts to surgical decompression • Novel physical performance tests for degenerative cervical myelopathy (DCM) • Artificial intelligence-assisted radiographic diagnosis for management triage • Exoskeleton and spinal cord stimulator-assisted rehabilitation programs

Pain

We promote multidisciplinary collaboration to improve the understanding and management of pain. • Multidisciplinary Pain Management Approaches • Understanding Pain Mechanisms • Clinical Evaluations and Quality of Life

Stroke

We unite the expertise of HKU Stroke and the Queen Mary Hospital (QMH) Stroke Team to advance stroke prevention, treatment, and recovery. Key research areas include: • Primary and secondary prevention of stroke • Cerebral small vessel disease • Intracerebral haemorrhage • Gut-brain-vascular axis in stroke prevention • Digital health solutions for stroke prevention and rehabilitation

Engage with CNC

Explore 

Discover our work, people, and areas of expertise 

Share 

Share collaboration ideas and research interests 

Connect 

Engage with CNC Chapters and networks 

Industry and Innovation Partners Medical device, biotech and pharmaceutical companies
CONTACT US to discuss partnership opportunities or to be connected with our Chapter leads 
HKU_LKS Faculty of Medicine_Master Full Logo_Black.png
CNC web logo_footer logo 2.png

Clinical Neuroscience Consortium

bottom of page